Inlay to Treat Presbyopia Gets US Approval

It is the first implantable device for the correction of near vision in presbyopic patients who have not had cataract surgery.

Read Article
  • Dry Eye Disease: Creating More Awareness

    Read Article
  • Tips to Build a Successful Laser-Assisted Cataract Surgery Model in Any Practice

    Read Article
  • Best Practices in Integrated Care

    Read Article


Are workplace #wellness programs voluntary? #health #repost @GlaucomaToday

Articles From This Issue


Inlay to Treat Presbyopia Gets US Approval

COVER FOCUS: Corneal Inlays In the USA

The FDA has approved the Kamra inlay (AcuFocus), a device that is implanted in a presbyopic patient’s cornea to improve near vision by extending the depth of focus. The …

The Sniff Test


Attending large national conventions such as those of the American Academy of Ophthalmology and the American Society of Cataract and Refractive Surgery (ASCRS) can be ove…


CRST Polls

View All

Is cost a viable reason to perform glaucoma surgery first?






Imprimis Pharmaceuticals Acquires Proprietary Compounded Conscious Sedation Form…

Imprimis Pharmaceuticals announced that it has acquired the rights to novel proprietary sedation and…

InSite Vision Announces Completion of the New Drug Application Submission to the…

InSite Vision announced that it has completed the submission for a new drug application (NDA) to the…


Video Series

Contact Info

Bryn Mawr Communications LLC
1008 Upper Gulph Road, Suite 200
Wayne, PA 19087

Phone: 484-581-1800
Fax: 484-581-1818

About CRST

Cataract & Refractive Surgery Today delivers cutting-edge information to cataract and refractive surgeons. Read by over 10,893 physicians, the publication promotes continuing education by covering such topics as surgical pearls, complications management, technological advances, and practice management.

Website Design by Sides Media